Avestar Capital, LLC

Position in CRDF — Cardiff Oncology, Inc.

CIK 1704404 New York, NY

Position in CRDF

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$176,988

-$43,566 QoQ

Shares Held

136,145

0.0% QoQ

Ownership

0.175%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#22

of 104 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Avestar Capital, LLC holds $2,161,613 across 4 Biotechnology names. CRDF ranks #3 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,898	$1,439,523
2	REGN	Regeneron Pharmaceuticals, Inc.	673	$419,642
3	CRDF	Cardiff Oncology, Inc. This page	136,145	$176,988
4	AGEN	Agenus Inc	41,000	$125,460

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$176,988	136,145	0.0%	Shares	Sole	2026-07-29
2026-03-31	$220,554	136,145	0.0%	Shares	Sole	2026-05-13
2025-12-31	$382,567	136,145	-3.1%	Shares	Sole	2026-02-10
2025-09-30	$289,366	140,469	0.0%	Shares	Sole	2025-11-07
2025-06-30	$442,477	140,469	0.0%	Shares	Sole	2025-08-13
2025-03-31	$441,072	140,469	0.0%	Shares	Sole	2025-05-14
2024-12-31	$609,635	140,469	0.0%	Shares	Sole	2025-01-29
2024-09-30	$375,052	140,469	0.0%	Shares	Sole	2024-11-13
2024-06-30	$311,841	140,469	—	Shares	Sole	2024-08-08
No filing history on record for this holder in this stock.